Rankings
▼
Calendar
LGVN Q2 2020 Earnings — Longeveron Inc. Revenue & Financial Results | Market Cap Arena
LGVN
Longeveron Inc.
$18M
Q2 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$876,000
Gross Profit
$112,000
12.8% margin
Operating Income
-$1M
-140.0% margin
Net Income
-$1M
-138.8% margin
EPS (Diluted)
$-0.76
QoQ Revenue Growth
-48.7%
Cash Flow
Operating Cash Flow
-$1M
Free Cash Flow
-$1M
Stock-Based Comp.
$11,000
← FY 2020
All Quarters
Q3 2020 →